cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Iradimed Corp
2 own
3 watching
Current Price
$42.36
$1.36
(3.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
521.64M
52-Week High
52-Week High
51.03700
52-Week Low
52-Week Low
36.12000
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
79.0861
iconMarket Capitalization521.64M
icon52-Week High51.03700
icon52-Week Low36.12000
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio79.0861
What does the Iradimed Corp do?
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Read More
How much money does Iradimed Corp make?
News & Events about Iradimed Corp.
Globe Newswire
1 year ago
WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the Company) (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a ...
Globe Newswire
1 year ago
Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32.Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and non-GAAP diluted EPS of $1.10.The Board of Directors approved a special cash dividend of $1.05 per share. ...
Globe Newswire
1 year ago
WINTER SPRINGS, Fla., Jan. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION(NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market opens on Thursday, February 2, 2023. IRADIMED management will host a conference call the same day ...
Globe Newswire
1 year ago
Reports preliminary fourth quarter 2022 revenue of $14.9 millionAnnounces full-year and first-quarter 2023 financial guidance WINTER SPRINGS, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the Company) (NASDAQ: IRMD) today announced selected preliminary financial results for the ...
Globe Newswire
1 year ago
Announces Preliminary Financial Results for Third Quarter 2022WINTER SPRINGS, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION(the Company) (NASDAQ: IRMD) today announced that the Company voluntarily withdrew its 510(K) application on October 5, 2022, for its next-generation MR IV pump. ...
Frequently Asked Questions
Frequently Asked Questions
What is Iradimed Corp share price today?
plus_minus_icon
Can Indians buy Iradimed Corp shares?
plus_minus_icon
How can I buy Iradimed Corp shares from India?
plus_minus_icon
Can Fractional shares of Iradimed Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Iradimed Corp stocks?
plus_minus_icon
What is today’s traded volume of Iradimed Corp?
plus_minus_icon
What is today’s market capitalisation of Iradimed Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Iradimed Corp?
plus_minus_icon
What percentage is Iradimed Corp down from its 52-Week High?
plus_minus_icon
What percentage is Iradimed Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$42.36
$1.36
(3.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$7.74
$-0.46 (-5.61 %)
CytoSorbents Corp
CytoSorbents Corp
$0.81
$0.01 (1.00 %)
BioLife Solutions, Inc.
BioLife Solutions, Inc.
$16.80
$0.94 (5.93 %)
UTAH MEDICAL PRODUCTS INC
UTAH MEDICAL PRODUCTS INC
$68.13
$-0.45 (-0.66 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
INFUSYSTEM HOLDINGS INC
INFUSYSTEM HOLDINGS INC
$7.74
$-0.46 (-5.61 %)
CytoSorbents Corp
CytoSorbents Corp
$0.81
$0.01 (1.00 %)
BioLife Solutions, Inc.
BioLife Solutions, Inc.
$16.80
$0.94 (5.93 %)
UTAH MEDICAL PRODUCTS INC
UTAH MEDICAL PRODUCTS INC
$68.13
$-0.45 (-0.66 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00